Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
| Detailed Information | |
|---|---|
| Biomarker ID | 1087 |
| PMID | 23538390 |
| Year | 2013 |
| Biomarker | miR-183 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Prostate Cancer |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- Gene expression (Transcription); Generic Transcription Pathway; RNA Polymerase II Transcription; synapse; glutamatergic synapse |
| Experiment | Tumor Stage pT2 Vs pT3 |
| Type of Biomarker | Prognostic |
| Cohort | 31 patients with Prostate Cancer and 31 adjacent normal Tissues were chosen for this analysis. 22 patients had stage pT2 and 9 had stage pT3 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | real-time PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | miR-183 |